Today: 1 May 2026
Browse Category

NASDAQ:LRCX 29 December 2025 - 6 January 2026

Lam Research stock jumps nearly 7% on fresh Aletheia “Buy” call as CES focus stays on AI

Lam Research stock jumps nearly 7% on fresh Aletheia “Buy” call as CES focus stays on AI

Lam Research shares jumped 6.9% to $208.15 Tuesday after Aletheia Capital initiated coverage with a buy rating and $260 target. Peers Applied Materials and KLA also rose. Investors await Lam’s Jan. 28 earnings for signals on chip equipment demand and 2026 spending. The rally follows increased focus on AI data-center buildouts and new product launches at CES.
6 January 2026
··
Lam Research stock (LRCX) jumps 5% as CES 2026 AI headlines fuel chip-equipment rally

Lam Research stock (LRCX) jumps 5% as CES 2026 AI headlines fuel chip-equipment rally

Lam Research closed up 5.3% at $194.76 Monday, holding gains after hours as chip-equipment stocks rallied sharply. Applied Materials, KLA, and ASML each rose over 5%, outpacing the semiconductor ETF. Investors tracked CES news and awaited Lam’s Jan. 28 earnings report. Foxconn reported record Q4 revenue on strong AI product demand.
6 January 2026
···
Lam Research stock today: LRCX jumps 8% on Citi list as chip-equipment rally builds

Lam Research stock today: LRCX jumps 8% on Citi list as chip-equipment rally builds

Lam Research shares jumped 8.1% to $185.06 Friday after being added to Citi’s Large Cap Recommended list for 2026, trading as high as $185.78. ASML rose 8.7%, while Applied Materials and KLA each gained nearly 5%. The move came on heavy volume, with Lam’s session low at $177.50 now seen as support. Investors await ISM manufacturing data Jan. 5 and Lam’s dividend Jan. 7.
4 January 2026
··
Lam Research stock jumps 8% to start 2026 as chip-tool shares rally — what LRCX investors watch next

Lam Research stock jumps 8% to start 2026 as chip-tool shares rally — what LRCX investors watch next

Lam Research shares surged 8.1% to $185.06 Friday, leading semiconductor equipment stocks after the U.S. changed licensing rules for chipmaking tool shipments to China. The Philadelphia Semiconductor Index rose about 4%. Investors are watching for further export-rule updates and Lam’s next earnings date, expected in late January or early February.
3 January 2026
··
Lam Research stock hits record after Citi adds LRCX to 2026 list, lifting chip gear peers

Lam Research stock hits record after Citi adds LRCX to 2026 list, lifting chip gear peers

Lam Research shares jumped 8.1% to $185.06 in after-hours trading Friday after Citi added the chip-equipment maker to its 2026 Large Cap Recommended list. The stock set a new intraday high, with gains supported by bullish calls from TD Cowen and Cantor Fitzgerald. Applied Materials and ASML also rose late. Investors are watching for Lam’s next earnings date and any signs of shifting demand in China.
3 January 2026
··
Applied Materials stock drops again as China’s “50% local tools” push weighs on AMAT

Applied Materials stock drops again as China’s “50% local tools” push weighs on AMAT

Applied Materials shares fell 1.1% to $256.99 Wednesday, extending a two-day slide as China moved to require chipmakers to use at least 50% domestic equipment for new semiconductor plants, Reuters reported. Lam Research dropped 1.5% and KLA lost 2.3%. TSMC said it received a U.S. export license for its Nanjing fab, allowing continued equipment shipments. Trading in Applied was light, with the stock closing about 7% below its recent high.
1 January 2026
····
Applied Materials stock snaps 7-day rally as China pushes “50% domestic tools” rule

Applied Materials stock snaps 7-day rally as China pushes “50% domestic tools” rule

Applied Materials shares fell 1.2% to $259.97 Tuesday, ending a seven-day rally. Lam Research and KLA also closed lower. Reuters reported China is requiring chipmakers to source at least half of new-fab equipment from domestic suppliers, raising uncertainty for U.S. toolmakers. U.S. granted Samsung and SK Hynix annual licenses for chip equipment shipments to China.
31 December 2025
····
Lam Research (LRCX) slips after report China tightens “50% domestic tools” push

Lam Research (LRCX) slips after report China tightens “50% domestic tools” push

Lam Research shares fell 1.2% to $173.78 in after-hours trading Tuesday after Reuters reported China now requires chipmakers to source at least 50% of equipment domestically for new capacity approvals. Applied Materials and KLA also declined, while ASML rose. The policy could pressure foreign suppliers like Lam, which derives about 93% of revenue from non-U.S. sales. Investors are watching for details on enforcement and possible waivers.
31 December 2025
··
Applied Materials stock slips as China’s 50% domestic chip-tool rule puts AMAT in the spotlight

Applied Materials stock slips as China’s 50% domestic chip-tool rule puts AMAT in the spotlight

Applied Materials shares fell 1.1% to $260.27 Tuesday after Reuters reported China now requires chipmakers expanding capacity to source at least 50% of equipment domestically. The iShares Semiconductor ETF was little changed. Wells Fargo raised its price target on Applied Materials to $290 and maintained an Overweight rating. Lam Research and KLA shares also slipped about 1%.
30 December 2025
·····
KLA stock dips as China’s 50% domestic chip-tool rule rattles semiconductor equipment names

KLA stock dips as China’s 50% domestic chip-tool rule rattles semiconductor equipment names

KLA shares fell 0.8% to $1,250.43 Tuesday after a Reuters report said China will require chipmakers to source at least half of new-fab equipment domestically. U.S. chip-equipment stocks tracked lower as traders awaited Federal Reserve minutes and eyed tightening export-license rules. Applied Materials and Lam Research also declined, while ASML rose.
30 December 2025
······
KLA stock drops after tech pullback hits chip equipment names; Fed minutes next

KLA stock drops after tech pullback hits chip equipment names; Fed minutes next

KLA Corp shares fell 1.5% to $1,260.39 Monday, ending a six-session winning streak as tech stocks retreated in thin year-end trading. The Philadelphia Semiconductor Index dropped 0.41%. KLA’s volume was lighter than usual, with 625,000 shares traded versus a 993,000 average. Investors await Fed minutes and jobless claims later this week.
30 December 2025
······
Lam Research near $180 as year-end positioning puts chip-tool stocks back in play

Lam Research near $180 as year-end positioning puts chip-tool stocks back in play

Lam Research closed up 0.4% at $178.07 Friday in thin post-holiday trading. Investors await December-quarter results after the quarter ended Sunday, with guidance set at $5.20 billion revenue plus or minus $300 million. Fed minutes due Tuesday and light volumes could drive volatility. Other chip-equipment stocks also edged higher.
29 December 2025
······
Lam Research stock steadies near $180 as investors eye Fed minutes and January earnings

Lam Research stock steadies near $180 as investors eye Fed minutes and January earnings

Lam Research shares closed at $178.07, up 0.4% in the latest session, outpacing broader indexes. Analysts cited in recent broker notes and reports expect a rebound in memory chip equipment spending in 2026. Investors are watching Fed minutes and economic data for rate signals ahead of Lam’s January earnings. The company’s fiscal quarter ended Sunday.
29 December 2025
···
1 … 4 5 6 7 8 9

Stock Market Today

  • Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK
    May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines and capital strategies amid challenging market conditions.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 12:12 AM EDT Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Go toTop